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Article Information  ABSTRACT 
Received: 25th Aug 2016  With an objective of synthesizing some novel, potent and broad spectrum antifungal activity 
having compounds, here some novel quinoline derivatives are reported. Initially 7-substituted-2-
cholro-3-formylquinolines were prepared using well known Vilsemeir-Hack reagent method. 
These on microwave irradiation with 4M HCl yielded 7-substituted-2-hydroxy quinoline-3-
carbaldehydes I(a, b), which on further treatment with different substituted hydrazides yielded 
the novel Schiff bases of quinoline II(a-f). The structure of all newly synthesized compounds 
was confirmed by spectral study such as IR, 1H NMR, 13C NMR and mass spectroscopy. All the 
synthesized compounds were screened for in-vitro antifungal activity by two fold serial dilution 
method using fluconazole as the standard drug. Compounds II a, II b and II d showed 
significant antioxidant activity 
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INTRODUCTION 
During last two decades, fungi have emerged as new life 
threatening agents, causing increased opportunistic infections 
in human and animals. In fact, overwhelming efforts of the 
medicinal chemists, it is not getting eradicated successfully. 
The unhygienic condition maintained by the people and dust 
induced infection being a prime reason for fungal infection to 
spread fast. Furthermore some of these organisms have earned 
a resistance to anti fungal drugs. In case of immuno 
compromised patients it spreads very fast. Thus there is a need 
to explore some novel antifungal agents. Quinoline ring system 
is a ubiquitous pharmacophore and an essential structural 
fragment of a large number of natural and synthetic compounds 
possessing versatile pharmacological activities like anti-
inflammatory [1,2], antitubercular [3,4,5], antiviral [6], 
antimalarial [7,8], anticancer [9,10], antibacterial [11], 
antioxidant [12], tyrosine kinase inhibitor [13], anticonvulsant 
and antihypertensive [14] etc. These findings encouraged us for 
synthesizing some novel quinoline Schiff base compounds.  
 In this research work initially 7-substituted-2-cholro-3-
formylquinolines on microwave irradiation with 4M HCl 
yielded 7-substituted-2-hydroxy quinoline-3-carbaldehydes I 
(a, b). IR spectra of these compounds showed characteristic 
peaks at around 3190 cm-1 (OH), 1680 cm-1 (C=O), 1620 cm-1 
(C=N), Further a novel series of quinoline Schiff bases II (a-f) 
were synthesized by the reaction between 7-substituted-2-
hydroxy quinoline-3-carbaldehydes I(a, b) and different 
hydrazides. IR spectra of these compounds showed 
characteristic peaks at around 3400 cm-1 (OH), 3100 cm-1 
(NH), 1650 cm-1 (C=O), 1610 cm-1 (C=N).. 1H NMR spectra of 
these compounds showed characteristic peaks at around δ 8.3 
and 12.25 ppm due to  protons of CH=N and OH respectively. 
13 C NMR spectra of these compounds showed characteristic 
peaks at around δ 138 and 156 ppm due to  carbon of CH=N 
and C=O respectively. 
 
MATERIALS AND METHOD 
General considerations 
The various chemicals used in the synthesis of the titled 
compounds were purchased from, Sigma-Aldrich Pvt Ltd, S.D. 
Fine Chem Pvt Ltd. Absolute ethanol and DMF utilized were 
purified according to the literature.  
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Melting points of all synthesized compounds were determined 
by open capillary method and are uncorrected. FTIR spectra 
were recorded on Bruker Alpha-T by using KBr pellets. The 
1HNMR were recorded on Bruker Avance II NMR 400 MHz 
instruments using DMSO as solvent and TMS as internal 
standard, chemical shifts are expressed as δ values (ppm). 
Elemental analysis was carried out for the synthesized 
compounds. All the physicochemical data are given in table 1. 
 
Antifungal activity 
In vitro anti fungal activity of the synthesized compounds was 
evaluated by two fold serial dilution method25. Media used was 
Potato Dextrose Broth (PDB). Initially, the stock culture of 
Aspergillus niger, Aspergillus flavus, Aspergillus terrius and 
Candida albicans were revived by inoculating in broth media 
and grown at 370C for 48 hrs. The tubes of the above media 
PDB (5 ml) were prepared and each tube was added with 
compounds (10-500 μg) and inoculated with 100 μl of 48 hr old 
cultures. The control tubes with fluconazole and DMSO were 
also prepared. All the tubes were incubated at 370C for 48 h 
with constant shaking and the absorbance of biomass were 
measured at 660 nm using shimadzu UV-Visible 
spectrophotometer against autoclaved, uninoculated media as 
blank. The result of in vitro anti fungal activity is expressed as 
Minimum Inhibitory concentration (MIC). Compounds II a, II 
b and II d showed significant antifungal activity. Table 2 
reveals antifungal activity (MIC) data for all the synthesized 
compounds. 
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Table 1: Physico-chemical data of the synthesized compounds II (a-f) 
Compound 
Molecular  
formula 
M.P°C %Yield 
Elemental Analysis 
Found (Calcd) % 
 
Solubility 
C H N 
II a C16H11FN4O2 246-248 71 
61.95 
(61.92) 
3.57 
(3.51) 
18.06 
(18.03) 
DMSO 
II b C16H11FN4O2 258-260 68 
61.95 
(61.93) 
3.57 
(3.53) 
18.06 
(18.02) 
DMSO 
II c C11H9N5O3S 232-234 64 
45.36 
(45.32) 
3.11 
(3.08) 
24.04 
(24.91) 
DMSO 
II d C11H9FN4OS 274-276 76 
49.99 
(49.95) 
3.43 
(3.42) 
21.20 
(21.16) 
 
DMSO 
II e C16H11 N5O4 224-226 70 
56.98 
(56.95) 
3.29 
(3.26) 
20.76 
(20.73) 
DMSO 
II f C16H11 N5O4 248-250 66 
56.98 
(56.97) 
3.29 
(3.27) 
20.76 
(20.75) 
DMSO 
 
Table 2: Antifungal activity screening results of newly synthesized compounds II (a-f) 
Compound 
MIC values (μg/ ml) 
A.niger  A.flavus A.terrius C.albicans 
II a 25  50 12.5 50 
II b 12.5  25 12.5 >100 
II c 50  >100 50 >100 
II d 50  100 12.5 25 
II e 12.5  50 >100 12.5 
II f 50  >100 100 12.5 
DMSO 
(Solvent) 
--  -- -- -- 
Fluconazole 6.25  6.25 6.25 6.25 
 
RESULTS 
General procedure for the synthesis of 7-substituted-2-
hydroxyquinoline-3-carbaldehyde      I(a,b) 
A mixture of 7-substituted-2-chloro-3-formylquinolines (0.01 
mol) and 4M HCl solution (30 ml) was subjected for MW 
irradiation (120 W) for 6 min. Yellow solid precipitated on 
cooling. This was poured into a beaker containing crushed ice 
(100 g), filtered, dried and recrystallised from glacial acetic 
acid. 
I a: IR (KBr) cm-1: 3192.54 (OH), 1681.35 (C=O), 1620.68 
(C=N) . 1H NMR (400 MHz, DMSO-d6, δ ppm): 7.18 (d, 1H, 
C6-H of quinoline), 7.46-7.51 (m, 1H, C8-H of quinoline), 7.85 
(d, 1H, C5-H of quinoline), 8.32 (s, 1H, C4-H of quinoline), 
10.23 (s, 1H, CHO), 12.57 (s, 1H, OH). 
I b: IR (KBr) cm-1: 3189.11 (OH), 1684.76 (C=O), 1621.17 
(C=N). 1H NMR (400 MHz, DMSO-d6, δ ppm): 7.21 (d, 1H, 
C6-H of quinoline), 7.49-7.57 (m, 1H, C8-H of quinoline), 7.85 
(d, 1H, C5-H of quinoline), 8.29 (s, 1H, C4-H of quinoline), 
10.46 (s, 1H, CHO), 12.29 (s, 1H, OH). 
 
General procedure for the synthesis of compounds II (a-f) 
A mixture of compound I (a, b) (0.005 mol) in 25 ml of 
absolute ethanol, equimolar amount of substituted hydrazides 
(0.005 mol) and catalytic amount of glacial acetic acid were 
added. The mixture was refluxed for 6 h. Solid compound was 
obtained on cooling the reaction mixture. This was filtered, 
dried and recrystallized from ethanol and DMF mixture to get 
the final compounds   II (a-f). 
Pradeep Kumar M R
 
Synthesis and antifungal activity screening of some novel 7-substituted -2-hydroxy-quinoline schiff bases   
 
 
Journal of Applied Pharmaceutical Research  October – December 2016  Volume 4 Issue 4  8 
II a: IR (KBr) cm-1: 3401.02 (OH), 3161.32 (NH), 1652.56 
(C=O), 1607.89 (C=N). 1H NMR (400 MHz, DMSO-d6, δ 
ppm): 7.24 - 8.31 (m, 9H, C4, C5, C6, C8-H of quinoline, CH=N 
& C2, C3, C5, C6-H of pyridine), 12.02 (s, 1H, NH), 12.25 (s, 
1H, OH). Mass (m/z): 310.68 
 
II b: IR (KBr) cm-1: 3408.19 (OH), 3162.79 (NH), 1648.25 
(C=O), 1612.31 (C=N), 1H NMR (400 MHz, DMSO-d6, δ 
ppm): 7.30 (s, 2H, C3 & C4-H of pyridine), 7.45 (s, 1H, C8-H of 
quinoline), 7.73 (s, 2H, C2 & C5-H of pyridine), 7.89 (s, 1H, 
C6-H of quinoline), 8.02 (s, 1H, C5-H of quinoline), 8.36 (s, 
1H, CH=N), 8.59 (s, 1H, C4-H of quinoline), 11.66 (s, 1H, 
NH), 12.18 (s, 1H, OH).        13C NMR (400 MHz, DMSO-d6, δ 
ppm): 162.46 (quinoline- C2), 160.23 (C=O), 151.02 (quinoline 
C9), 144.22 (CH=N), 140.67 (pyridine- C4), 135.46 (quinoline- 
C4), 132.65 (quinoline- C7), 127.63 (pyridine- C3 and -C5), 
125.32 (quinoline- C5), 123.16 (pyridine- C2 and -C6),  121.44 
(quinoline- C8), 120.19 (quinoline- C6), 118.21 (quinoline- 
C10), 115.44 (quinoline- C3). 
Mass (m/z): 310.02 
 
II c: IR (KBr) cm-1: 3409.14 (OH), 3104.41 (NH), 1681.74 
(C=O), 1615.22 (C=N), 1H NMR (400 MHz, DMSO-d6, δ 
ppm): 7.31 (d, 1H, C8-H of quinoline), 7.43 (d, 1H, C6-H of 
quinoline), 7.59 (s, 1H, C5-H of quinoline), 8.32(s, 1H, C4-H of 
quinoline), 8.62(s, 2H, NH2), 8.78(s, 1H,  CH=N), 11.13 (s, 1H, 
NH), 12.17 (s, 1H, OH). 
Mass (m/z): 291.06 
 
II d: IR (KBr) cm-1: 3416.10 (OH), 3133.21 (NH), 1659.04 
(C=O), 1606.72 (C=N), 1H NMR (400 MHz, DMSO-d6, δ 
ppm): 7.29 (d, 1H, C8-H of quinoline), 7.47 (d, 1H, C6-H of 
quinoline), 7.59 (s, 1H, C5-H of quinoline), 8.24 (s, 1H, C4-H 
of quinoline), 8.59 (s, 2H, NH2), 8.77 (s, 1H,  CH=N), 11.54 (s, 
1H, NH), 12.17 (s, 1H, OH). 
Mass (m/z): 264.85 
 
II e: IR (KBr) cm-1: 3411.78 (OH), 3103.61 (NH), 1642.20 
(C=O), 1610.32 (C=N), 1H NMR (400 MHz, DMSO-d6, δ 
ppm): 7.21 (s, 2H, C3 & C4-H of pyridine), 7.34 (s, 1H, C8-H of 
quinoline), 7.61 (s, 2H, C2 & C5-H of pyridine), 7.79 (s, 1H, 
C6-H of quinoline), 7.98 (s, 1H, C5-H of quinoline), 8.56 (s, 
1H, CH=N), 8.81 (s, 1H, C4-H of quinoline), 11.39 (s, 1H, 
NH), 12.11 (s, 1H, OH).  
Mass (m/z): 337.31 
II f: IR (KBr) cm-1: 3418.76 (OH), 3146.22 (NH), 1644.82 
(C=O), 1619.29 (C=N), 1H NMR (400 MHz, DMSO-d6, δ 
ppm): 7.44-8.85 (m, 9H, C4, C5, C6, C8-H of quinoline, CH=N 
& C2, C3, C5, C6-H of  pyridine), 11.18 (s, 1H, NH), 12.35 (s, 
1H, OH).13C NMR (400 MHz, DMSO-d6, δ ppm): 162.44 
(quinoline- C2), 161.53 (C=O), 151.32 (quinoline C9), 141.85 
(CH=N), 139.88 (pyridine- C4), 136.66 (quinoline- C4), 131.04 
(quinoline- C7), 128.11 (pyridine- C3 and -C5), 123.38 
(quinoline- C5), 122.76 (pyridine- C2 and -C6),  121.02 
(quinoline- C8), 120.77 (quinoline- C6), 118.59 (quinoline- 
C10), 116.63 (quinoline- C3). 
Mass (m/z): 337.57 
 
DISCUSSION 
A novel series of quinoline Schiff bases II (a-f) have been 
synthesized by reacting 7-substituted/unsubstituted-2-hydroxy-
3-formylquinolines I (a, b) with substituted hydrazides. The 
purity of the synthesized compounds was confirmed by TLC. 
The structure of all the newly synthesized compounds was 
confirmed by physicochemical and spectral data. All the 
compounds were screened for their antifungal activities using 
two fold serial dilution method, Among the series II (a-f), 
compound II a showed significant antifungal activity against 
A.terrius. Compound II b showed significant antifungal 
activity against A.niger and A.terrius Compound II d showed 
significant antifungal activity against A.terrius, Compounds II 
e and II f showed significant antifungal activity against 
C.albicans. Compounds II c has showed moderate antifungal 
activity against A.niger and A.terrius. Compounds II a, II b 
and II d containing fluorine at the 7th position of quinoline 
shown significant antifungal activity against the tested 
organisms 
 
CONCLUSION 
In the series II (a-f) it is evidently observed that the antifungal 
activity of the compounds has been greatly influenced by the 
presence of fluorine as a substituent on the quinoline nucleus. 
Quinoline moiety and its Schiff bases do contribute for the 
observed activity but the presence of fluorine at 7th position of 
quinoline contributed for its significant antifungal activity. The 
preliminary antifungal activity screening result of these 
compounds depicted them as potential antifungal leads 
endowed with moderate to excellent activity. Further 
enhancement in the activity can be achieved by slight 
modifications in the ring substituent 
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Term Expansion/ Full form 
UV Ultra violet 
FTIR Fourier Transform Infrared Radiation 
NMR Nuclear Magnetic Resonance 
TMS Tetra Methyl Silane 
DMSO Dimethyl sulfoxide 
nm Nanometer 
DMSO-d6 Deuterated Dimethyl sulfoxide 
MW irradiation Microwave irradiation 
